# OnCo record inv-9956 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/inv-9956/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "inv-9956" ;
  schema:name "INV-9956"@en ;
  schema:description "INV-9956 is an experimental CYP11A1 inhibitor from Shenzhen Ionova Life Sciences, in phase 2 trials for metastatic castration-resistant prostate cancer."@en ;
  schema:url <https://onco.cc/drugs/inv-9956/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.ionovabio.com/en/companynews>, <https://www.ionovabio.com/en/companynews>, <https://clinicaltrials.gov/api/v2/studies/NCT06609005>, <https://clinicaltrials.gov/search?intr=INV-9956> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "CYP11A1 inhibitor" ;
  onco:cancers <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:targets <https://onco.cc/targets/cyp11a1/> ;
  onco:companies <https://onco.cc/companies/shenzhen-ionova-life-sciences/> ;
  onco:trials <https://onco.cc/trials/nct06609005/> .